| Authors: |
Goldman JW; University of California Los Angeles, Santa Monica, CA. Electronic address: jwgoldman@mednet.ucla.edu., Bueno AM; Hospital Quirón Dexeus, Oncology, Barcelona, Spain., Dooms C; University Hospitals Leuven, Respiratory Diseases, Leuven, Belgium., Jhaveri K; Memorial Sloan Kettering Cancer Center, New York, NY., de Miguel M; START-CIOCC HM Sanchinarro, Medical Oncology, Madrid, Spain., Piha-Paul SA; The University of Texas MD Anderson Cancer Center, Houston, TX., Unni N; The University of Texas Southwestern Medical Center, Dallas, TX., Zick A; Hadassah Medical Center Hebrew University of Jerusalem, Oncology, Jerusalem, Israel., Mahipal A; Mayo Clinic, Rochester, MN., Suga JM; Kaiser Permanente, Oncology, Vallejo, CA., Naltet C; Gustave Roussy, Medical Oncology, Villejuif, France., Antoñanzas M; Hospital Clínico San Carlos, Oncology, Madrid, Spain., Crown J; St Vincent's University Hospital, Oncology, Dublin, Ireland., Bebchuk J; Puma Biotechnology Inc., Los Angeles, CA., Eli LD; Puma Biotechnology Inc., Los Angeles, CA., Lowenthal BH; Puma Biotechnology Inc., Los Angeles, CA., Mahalingam D; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Medicine, Chicago, IL. |
